Follow on Google News News By Tag * Companion Diagnostics * Diagnostics * companion Dx * Next-generation Sequencing * Companion Dx Stakeholders * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Announcing the Companion Diagnostics: Strategy & Partnerships 2014 AgendaInternationally recognized event for pharma and diagnostics executives, translational scientists, clinicians, business experts, regulators, int'l companion Dx leaders, & other parties involved in drug-diagnostics co-development & precision medicine.
Conference sessions include: • Convening major stakeholders • New partnership paradigm • Going global and going NGS: regulatory perspective • Plenary session: Think tank on next-generation sequencing diagnostics Speakers include: J. Carl Barrett, Ph.D., AstraZeneca Catherine Brownstein, M.D., Harvard Medical School and Boston Children’s Hospital Tracy Bush, Ph.D., Roche Diagnostics Jennifer Dickey, RAC, Ph.D., US Food and Drug Administration Andrea Ferreira-Gonzalez, Ph.D., Virginia Commonwealth University Carlos Gil Ferreira, M.D., Brazilian National Cancer Institute Eric T Fung, M.D., Ph.D., Affymetrix Kevin M. Harter, Saladax Biomedical Matthew J. Hawryluk, Ph.D., Foundation Medicine, Inc. Madhuri Hegde, Ph.D., FACMG, Emory University School of Medicine Eric Lai, Ph.D., Takeda Pharmaceuticals Sabah Malek, Eisai, Inc. Frank S. Ong, M.D., Illumina, Inc. David Parker, Ph.D., Precision for Medicine Nick Poulios, Ph.D., Roche Molecular Systems, Inc. Mitch Raponi, Clovis Oncology Judi Smith, Vice President,Precision for Medicine John Quackenbush, Ph.D., GenoSpace / Dana-Farber Cancer Institute and Harvard School of Public Health Writers and editors are invited to attend. To request a press pass, email Lisa Scimemi, lscimemi@healthtech.com. For more information, visit http://www.NextGenerationDx.com/ About Next Generation Dx Summit Access to next generation diagnostics will only be gained through careful creation and management of partnerships in the community around development, commercialization, reimbursement and regulation. This year’s Next Generation Dx Summit will showcase advances in personalized medicine through a comprehensive program encompassing companion diagnostics, infectious disease, cancer molecular markers, point-of-care, inherited disorders, cell free DNA and single cell sequencing. This event has become the meeting place for major players in the expanding arena of diagnostics. It will showcase key components of their successful adoption in the clinic and advancement to the market. http://www.NextGenerationDx.com About Cambridge Healthtech Institute (CHI) Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation. http://www.chicorporate.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|